SEC Tracker
Get the app

MBX Biosciences MBX

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when MBX Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  2. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  3. Annexon ANNX public float $244M, Jun 30, 2025
  4. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  5. DBV Technologies DBVT public float $251M, Jun 30, 2025